Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study

Brain Hemosiderin and Superficial Siderosis of the Central Nervous System

Arnulf H. Koeppen, Mark P. Dentinger · Journal of Neuropathology & Experimental Neurology · 1988 · 165 citations

Medicine, Neurobiology, Neuroscience +10

Deferiprone in <scp>F</scp>riedreich ataxia: A 6‐Month randomized controlled trial

Massimo Pandolfo, Javier Arpa, Martin B. Delatycki et al. · Annals of Neurology · 2014 · 131 citations

Medicine, Neurology, Pharmacology +13

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

Giovanni Abbruzzese, Giovanni Cossu, Manuela Balocco et al. · Haematologica · 2011 · 129 citations · Full text

Medicine, Neurology, Neuroscience +17

The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1′ ol]-2-methyl-3-hydroxypyridin-4-one in the rat

A M Fredenburg, Rajiv K. Sethi, David D. Allen et al. · Toxicology · 1996 · 93 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up

Giovanni Cossu, Giovanni Abbruzzese, Gildo Matta et al. · Parkinsonism & Related Disorders · 2014 · 90 citations

Medicine, Neuroscience, Pharmacology +11